Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
SOL Strategies to acquire Houdini Swap for $18 million
-
SOL Strategies Announces Definitive Agreement to Acquire Houdini Swap, Expanding Privacy Focus and Acquiring Diversified Revenue Streams
-
Gold Strike Announces Closing of Transaction to Acquire Florin, FLR and RJ Gold Projects and Satisfies Release Conditions for $17.2 Million Escrowed Financing
-
QuantumCore to Present at Canaccord Genuity Virtual Quantum Symposium
-
Pantheon Resources PLC Announces Blocklisting Interim Update
-
Brazil Potash prices $55 million public offering at $2.50 per share
-
Brazil Potash Announces Pricing of $55 Million Public Offering of Common Shares and Pre-Funded Warrants
-
Element 29 names Dylan Berg as VP of investor relations and marketing
-
Element 29 Appoints Vice President, Investor Relations and Marketing
-
Form 8.3 - [ANIMALCARE GROUP PLC - 30 04 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 30 04 2026] - (CGWL)
-
Alpha Exploration Closes First Tranche of Private Placement Financing
-
Techcyte Announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability
-
Brazil Potash Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
-
Total Voting Rights
-
Nuvau Minerals Announces Grant of Options and Provides Update on Finder's Fees and Commissions
-
Lumina Metals Announces Closing of Upsized Initial Public Offering
-
Life & Banc Split Corp. Completes Preferred Share Offering
-
Selkirk Copper closes $35 million private placement for Minto project
-
Selkirk Copper Announces Closing of Upsized $35 Million Bought Deal Private Placement
-
Eco (Atlantic) Oil and Gas Ltd Announces Exercise of Options
-
Form 8.3 - [TREATT PLC - OPENING DISCLOSURE - 29 04 2026] - (CGAM)
-
Form 8.3 - [ANIMALCARE GROUP PLC - 29 04 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 29 04 2026] - (CGWL)
-
Amaroq doubles revolving credit facility to $70 million
-
Amaroq Doubles Revolving Credit Facility to US$70 Million
-
Transaction in Own Shares
-
Markette Ventures Opens the Market
-
GH Research prices $117.5 million share offering at $18 per share
-
GH Research Announces Pricing of $117.5 Million Underwritten Offering
-
Selkirk First Nation exercises participation right in Selkirk Copper
-
Selkirk Copper Announces Private Placement as Selkirk First Nation Exercises Participation Right
-
Form 8.3 - [ANIMALCARE GROUP PLC - 28 04 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 28 04 2026] - (CGWL)
-
Notice of Results and further details for Capital Markets Update
-
Arrow Announces 2025 Audited Year End and Q4 2025 Results, Filing of Audited Financial Statements, MD&A and Reserves Report
-
Notice of Results and further details for Capital Markets Update
-
MRF 2026 Resource Limited Partnership Closes IPO
-
Net Asset Value(s)
-
Rare Earths Americas launches IPO with 2.8 million shares priced at $17-19
-
Rare Earths Americas Announces Launch of Initial Public Offering
-
Form 8.3 - [ANIMALCARE GROUP PLC - 27 04 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 27 04 2026] - (CGWL)
-
Blue Moon Metals Confirms Final Investment Decision to Construct Nussir Project Mine, Intention to Construct the Springer Tungsten Mine and Concurrent C$150 Million Bought Deal Equity Offerings
-
Pantheon Resources PLC Announces Vesting of Previously Granted RSUs and TVR
-
New Found Gold Closes Bought Deal Financing Including Full Exercise of Underwriters' Over-Allotment Option for Gross Proceeds of $115M
-
Sagimet prices $175 million stock offering at $6 per share
-
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
-
D-Wave Quantum to Participate in Upcoming Investor Conferences
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 24 04 2026] - (CGWL)

